- Published at
- by seekingalpha.com
neutral
neutral
Indivior PLC 2020 Q4 - Results - Earnings Call Presentation (OTCMKTS:INVVY)
The following slide deck was published by Indivior PLC in conjunction with their 2020 Q4 earnings call.
News for Indivior PLC (2IV.BE)
- Published at
- by marketscreener.com
positivepositivePress Release : Addex Provides Trading Update and Completes 2020 with Strong Cash Position of CHF18.7 million
Geneva, Switzerland, February 17, 2021 -- https://www.globenewswire.com/Tracker?data=x7m9iGcmcrO8Ea211FsG1YHOEG0nqizO3vBGnCIH6eSX9fdeMZA80zGeiCebm4jj1oQY8BTr08sTjFFwIF6oD2Ja0mUnaWpimZy_Sheccgk=... | February 17, 2021- Published at
- by marketscreener.com
mixedmixedPress Release : Addex ADX71149 Receives IND Approval to Start a Phase 2a Clinical Study in Epilepsy
First patient treated with ADX71149 scheduled for Q2 2021 Geneva, Switzerland, January 21, 2021 --... | January 21, 2021- Published at
- by markets.businessinsider.com
mixedmixedAddex ADX71149 Receives IND Approval to Start a Phase 2a Clinical Study in Epilepsy
First patient treated with ADX71149 (JNJ-40411813) scheduled for Q2 2021Geneva, Switzerland, January 21, 2021 – Addex Therapeutics (SIX: ADX...- Published at
- by benzinga.com
mixedmixedOpioid Use Disorder Market Worth USD 4.87 Billion at 8.7% CAGR by 2027 Backed by Increasing Number of Opioid Dependence Patients in North America
Pune, India, Jan. 13, 2021 (GLOBE NEWSWIRE) -- The global opioid use disorder market is expected to experience exponential growth by reaching USD 4.87 ...- Published at
- by globenewswire.com
mixedmixedOpioid Use Disorder Market Worth USD 4.87 Billion at 8.7% CAGR by 2027 Backed by Increasing Number of Opioid Dependence Patients in North America
Key Prominent Players Covered in the Opioid Use Disorder Market Research Report Are Indivior PLC, Alkermes, Orexo AB, Titan Pharmaceuticals, Inc., Teva Pharmaceutical Industries Ltd., Mallinckrodt, Pharmaceuticals, BioDelivery Sciences International Inc., Viatris Inc., Pfizer, Inc., Hikma Pharmaceuticals PLC, Camurus Ltd. and other key market players.- Published at
- by marketscreener.com
neutralneutralPress Release: Addex Successfully Completes $11.5 Million Capital Increase Including Full Exercise of Underwriter's Option to Purchase Additional Securities
Geneva, Switzerland, January 11, 2021 -- Addex Therapeutics... | January 11, 2021- Published at
- by marketscreener.com
mixedmixedAddex Successfully Completes $11.5 Million Capital Increase Including Full Exercise of Underwriter's Option to Purchase Additional Securities
Geneva, Switzerland, January 11, 2021 – Addex Therapeutics Ltd , a clinical-stage pharmaceutical company pioneering allosteric modulation-based drug discovery and development, announced... | January 11, 2021